Altogether, these findings show that some parameters such as IL-6, IL-8, type I IFNs, CRP, neutrophil and platelet counts presented significant differences in patients with severe COVID-19 with different clinical outcomes (deceased versus discharged). This evidence concerns the gene CXCL8 and COVID-19.